CAAS Capital Management’s CVS Health CVS Stock Holding History

CAAS Capital Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$2.27M	Buy	+33,500	New	+$2M	0.24%	96
2024 Q1	–	Sell	-13,400	Closed	-$1.06M	–	540
2023 Q4	$1.06M	Sell	13,400 -4,100	-23%	-$292K	0.11%	179
2023 Q3	$1.22M	Sell	17,500 -84,000	-83%	-$5.95M	0.08%	236
2023 Q2	$7.02M	Buy	101,500 +93,700	+1,201%	+$6.67M	0.47%	54
2023 Q1	$580K	Buy	+7,800	New	+$654K	0.03%	368
2022 Q3	–	Sell	-10,000	Closed	-$927K	–	864
2022 Q2	$927K	Sell	10,000 -87,700	-90%	-$8.56M	0.05%	400
2022 Q1	$9.89M	Buy	97,700 +59,700	+157%	+$6.27M	0.41%	79
2021 Q4	$3.92M	Hold	38,000	–	–	0.1%	214
2021 Q3	$3.23M	Hold	38,000	–	–	0.06%	273
2021 Q2	$3.17M	Sell	38,000 -12,000	-24%	-$983K	0.05%	314
2021 Q1	$3.76M	Buy	+50,000	New	+$3.64M	0.04%	423

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CAAS Capital Management's CVS Position: Q3 2023 in Review

CAAS Capital Management sold out of CVS Health (CVS) in Q3 2023, closing a stake of 20,570 shares — an estimated $1.46M sold.

CAAS Capital Management first reported a position in CVS in Q2 2021 and held it in 6 quarters. The position peaked at $1.42M in Q2 2023. 2,113 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

CAAS Capital Management reported no remaining CVS Health position as of Q3 2023 after selling out during the quarter.
CAAS Capital Management sold 20,570 CVS Health shares in Q3 2023, an estimated $1.46M.
CAAS Capital Management first reported a position in CVS Health in Q2 2021 and held it in 6 quarters.
CAAS Capital Management's CVS Health position peaked at $1.42M in Q2 2023.
2,113 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on CAAS Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.